After Monsanto, Defense Bar Must Build Case Against Lohr

Start
For three decades, the medical device defense bar has litigated preemption under a framework that even its authors could not agree upon. Medtronic Inc. v. Lohr, decided by the U.S. Supreme Court in 1996, produced a fractured plurality that grafted two glosses onto the express preemption clause of the Medical Device Amendments, or MDA, at Title 21 of the U.S. Code, Section 360k(a). Originally published in Law360 on August 6, 2026….
By: Blank Rome LLP
Previous Story

[Video] Episode 440– Chris Focacci: AI, Due Diligence, and the Limits of Machine Judgment

Next Story

Now, It’s Serious: What New York’s 2026 Auto Insurance and Tort Reforms Mean for Serious Injury Claims and Comparative Fault